Skip to main content

Riluzol Pro.med.cs Praha 50 mg comprimidos recubiertos con película

Prescription request online

Prescription request online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

Doctor
5.0(24)

Taisiia Proida

Psychiatry7 years of experience
Licence no. 70352

Taisiia Proida is a general practitioner with a specialization in mental health and a cognitive behavioral therapist (CBT), a member of the European Psychiatric Association. She offers online consultations for adults aged 18 and over, combining evidence-based medicine with an individualised approach to mental health care. She specialises in consultations and ongoing support for a wide range of mental health concerns, including: 

  • Mood disorders: depression, bipolar disorder, postpartum depression.
  • Anxiety disorders: generalised anxiety, OCD, panic attacks, phobias.
  • Post-traumatic stress disorder (PTSD) and complex PTSD.
  • Attention deficit hyperactivity disorder (ADHD) and autism spectrum disorder (ASD). Assessment is provided only after an initial psychiatric evaluation and during a follow-up appointment.
  • Personality disorders and emotional instability.
  • Cyclothymia and mood fluctuations.
  • Schizophrenia spectrum and related conditions.

Dr. Proida combines clinical expertise with an empathetic approach, offering structured support based on evidence-based practices. Her work integrates CBT techniques with medical management, with a focus on anxiety and depressive disorders. She works with clients from different countries and cultural backgrounds, adapting her communication style and recommendations to individual needs. With experience in international clinical trials (Pfizer, Merck), she values clarity, trust, and collaborative partnership in patient care.

Book a video appointment
€170
This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use RILUZOL PMCS 50 mg FILM-COATED TABLETS

Contents of the leaflet

  1. Introduction
  2. What is Riluzol PMCS 50 mg film-coated tablets EFG and what is it used for
  3. What you need to know before taking Riluzol PMCS 50 mg film-coated tablets EFG
  4. How to take Riluzol PMCS 50 mg film-coated tablets EFG
  5. Possible side effects
  6. Storage of Riluzol PMCS 50 mg film-coated tablets EFG
  7. Package contents and additional information

Introduction

Leaflet: information for the user

Riluzol PMCS 50 mg film-coated tablets EFG

(riluzol)

Read the entire leaflet carefully before starting to take the medicine, as it contains important information for you.

  • Keep this leaflet, as you may need to read it again.
  • If you have any questions, consult your doctor or pharmacist.
  • This medicine has been prescribed to you only, and you should not give it to others, even if they have the same symptoms, as it may harm them.
  • If you experience side effects, consult your doctor or pharmacist, even if they are side effects not listed in this leaflet. See section 4.

Contents of the leaflet:

  1. What is Riluzol PMCS 50 mg film-coated tablets EFG and what is it used for
  2. What you need to know before taking Riluzol PMCS 50 mg film-coated tablets EFG
  3. How to take Riluzol PMCS 50 mg film-coated tablets EFG
  4. Possible side effects
  5. Storage of Riluzol PMCS 50 mg film-coated tablets EFG
  6. Package contents and additional information

1. What is Riluzol PMCS 50 mg film-coated tablets EFG and what is it used for

The active substance of Riluzol PMCS 50 mg film-coated tablets EFG is riluzole, which acts on the nervous system.

Riluzol PMCS 50 mg film-coated tablets EFG are used in patients with amyotrophic lateral sclerosis (ALS).

ALS is a form of motor neuron disease in which the damage to the nerve cells responsible for sending instructions to the muscles leads to weakness, muscle loss, and paralysis.

The destruction of nerve cells in motor neuron disease may be due to the presence of too much glutamate (a chemical messenger) in the brain and spinal cord. Riluzol PMCS 50 mg film-coated tablets EFG stop the release of glutamate, which may help prevent damage to nerve cells.

Consult your doctor for more information about ALS and why this medicine has been prescribed for you.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before taking Riluzol PMCS 50 mg film-coated tablets EFG

Do not take Riluzol PMCS 50 mg film-coated tablets EFG

  • if you are allergic to riluzole or any of the other ingredients of this medicine (listed in section 6).
  • if you have any liver disease or high blood levels of certain liver enzymes (transaminases).
  • if you are pregnant or breastfeeding.

Warnings and precautions

Consult your doctor or pharmacist before taking Riluzol PMCS 50 mg film-coated tablets EFG:

  • if you have any type of liver problem: yellowing of the skin or whites of the eyes (jaundice), itching all over the body, nausea, vomiting.
  • if your kidneys do not work well.
  • if you notice any sign of fever: it may be due to a reduced number of white blood cells, which may increase the risk of infection.

If you are in any of the above situations or have doubts, inform your doctor, who will decide what to do.

Children and adolescents

If you are under 18 years old. The use of Riluzol PMCS 50mg film-coated tablets EFG is not recommended in children due to the lack of available information in this population.

Other medicines and Riluzol PMCS 50 mg film-coated tablets EFG

Tell your doctor or pharmacist if you are using, have recently used, or might use any other medicine.

Pregnancy and breastfeeding

If you are pregnant, breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medicine.

DO NOT take Riluzol PMCS 50 mg film-coated tablets EFG if you are or think you may be pregnant or if you are breastfeeding.

Driving and using machines

You can drive or use any type of machine or tool, unless after taking this medicine you feel dizzy or faint.

Riluzol PMCS contains sodium

This medicine contains less than 23 mg of sodium (1mmol) per dose; it is essentially "sodium-free."

3. How to take Riluzol PMCS 50 mg film-coated tablets EFG

Follow the exact instructions for taking this medicine as indicated by your doctor. If in doubt, consult your doctor or pharmacist again.

The recommended dose is one tablet, twice a day. The tablets should be taken orally, every 12 hours, at the same time each day (e.g., in the morning and at night).

If you take more Riluzol PMCS 50 mg film-coated tablets EFG than you should

If you take too many tablets, go to your doctor or the nearest hospital emergency department immediately.

In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone 91 562 04 20, indicating the medicine and the amount.

If you forget to take Riluzol PMCS 50 mg film-coated tablets EFG

If you forget to take a tablet, skip that dose completely and take the next tablet at the usual time. Do not take a double dose to make up for the missed doses.

If you have any other questions about the use of this medicine, ask your doctor or pharmacist.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everyone gets them.

IMPORTANT

Tell your doctor immediately

  • if you notice any sign of fever (increased temperature), as Riluzol PMCS 50 mg film-coated tablets EFG may cause a decrease in the number of white blood cells. Your doctor may want to take a blood sample to check the number of white blood cells, which are important in fighting infections.
  • if you experience any of the following symptoms: yellowing of the skin or whites of the eyes (jaundice), generalized itching, feeling of dizziness or nausea, as they may be signs of liver disease (hepatitis). Your doctor may perform periodic blood tests while you are taking Riluzol PMCS 50 mg film-coated tablets EFG to ensure this does not happen.
  • if you experience cough or difficulty breathing, as they may be signs of lung disease (called interstitial lung disease).

Other side effects

Very common side effects(may affect more than 1 in 10 people):

  • fatigue,
  • dizziness,
  • high blood levels of certain liver enzymes (transaminases).

Common side effects(may affect up to 1 in 10 people):

  • vertigo,
  • drowsiness,
  • headache,
  • numbness or tingling of the mouth,
  • increased heart rate,
  • abdominal pain,
  • vomiting,
  • diarrhea,
  • pain.

Uncommon side effects(may affect up to 1 in 100 people):

  • anemia,
  • allergic reactions,
  • pancreatitis (inflammation of the pancreas).

Frequency not known(cannot be estimated from available data):

  • skin rash.

Reporting side effects

If you experience any side effects, consult your doctor or pharmacist, even if they are possible side effects not listed in this leaflet. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: https://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storage of Riluzol PMCS 50 mg film-coated tablets EFG

Keep this medicine out of the sight and reach of children.

No special storage conditions are required.

Do not use this medicine after the expiration date stated on the blister pack and carton after EXP. The expiration date is the last day of the month indicated.

Medicines should not be disposed of via wastewater or household waste. Deposit the packaging and any unused medicine in the pharmacy's SIGRE point. Ask your pharmacist how to dispose of the packaging and any unused medicine. This will help protect the environment.

6. Package contents and additional information

Composition of Riluzol PMCS 50 mg film-coated tablets EFG

The active substance is riluzole. Each film-coated tablet contains 50 mg of riluzole.

The other ingredients are:

Core of the tablet: anhydrous calcium hydrogen phosphate, granulated microcrystalline cellulose, sodium croscarmellose, anhydrous colloidal silica, magnesium stearate.

Film coating: hypromellose, titanium dioxide (E171), macrogol 400.

Appearance of the product and package contents

Riluzol PMCS 50 mg film-coated tablets EFG are round, biconvex, almost white film-coated tablets, 8 mm in diameter.

Riluzol PMCS 50 mg film-coated tablets EFG are available in packs of 10, 30, 50, 56, 60, 90, and 100 film-coated tablets.

Not all pack sizes may be marketed.

Marketing authorization holder and manufacturer

PRO.MED.CS Praha a.s., Telcská 377/1, Michle, Praha 4, 140 00, Czech Republic

This medicine is authorized in the Member States of the European Economic Area under the following names:

Austria Riluzol PMCS 50 mg Filmtabletten

Czech Republic Riluzol PMCS

Denmark Riluzol PMCS 50 mg filmovertrukne tabletter

Spain Riluzol PMCS 50 mg comprimido recubierto con película

France Riluzole PMCS 50 mg, comprimé pelliculé

Poland Riluzol PMCS

Romania Riluzol PMCS 50 mg comprimate filmate

Sweden Riluzol PMCS 50 mg filmdragerade tabletter

Slovakia Riluzol PMCS 50 mg filmom obalené tablety

Date of the last revision of this leaflet:

Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es.

Online doctors for RILUZOL PMCS 50 mg FILM-COATED TABLETS

Discuss questions about RILUZOL PMCS 50 mg FILM-COATED TABLETS, including use, safety considerations and whether a prescription is appropriate, subject to medical assessment and local regulations.

Doctor
5.0(24)

Taisiia Proida

Psychiatry7 years of experience
Licence no. 70352

Taisiia Proida is a general practitioner with a specialization in mental health and a cognitive behavioral therapist (CBT), a member of the European Psychiatric Association. She offers online consultations for adults aged 18 and over, combining evidence-based medicine with an individualised approach to mental health care. She specialises in consultations and ongoing support for a wide range of mental health concerns, including: 

  • Mood disorders: depression, bipolar disorder, postpartum depression.
  • Anxiety disorders: generalised anxiety, OCD, panic attacks, phobias.
  • Post-traumatic stress disorder (PTSD) and complex PTSD.
  • Attention deficit hyperactivity disorder (ADHD) and autism spectrum disorder (ASD). Assessment is provided only after an initial psychiatric evaluation and during a follow-up appointment.
  • Personality disorders and emotional instability.
  • Cyclothymia and mood fluctuations.
  • Schizophrenia spectrum and related conditions.

Dr. Proida combines clinical expertise with an empathetic approach, offering structured support based on evidence-based practices. Her work integrates CBT techniques with medical management, with a focus on anxiety and depressive disorders. She works with clients from different countries and cultural backgrounds, adapting her communication style and recommendations to individual needs. With experience in international clinical trials (Pfizer, Merck), she values clarity, trust, and collaborative partnership in patient care.

Book a video appointment
€170
Doctor
5.0(7)

Anastasiia Hladkykh

Psychiatry15 years of experience

Dr Anastasiia Hladkykh is a physician-psychotherapist and psychologist with over 14 years of experience working with individuals struggling with various types of addictions and their families. She provides online consultations for adults, combining medical knowledge with deep psychological support and practical tools.

Key areas of expertise:

  • Addiction treatment: alcohol and drug dependence, gambling addiction, compulsive behaviours, codependent relationships.
  • Support for families of addicted individuals, behavioural correction within the family system, guidance for maintaining remission.
  • Mental health: depression, bipolar disorder, obsessive-compulsive disorder (OCD), anxiety disorders, phobias, PTSD, generalised anxiety, emotional trauma, and the psychological impact of loss or emigration.
  • Psychoeducation: explaining complex mental health concepts in simple language, helping patients and their families understand diagnoses and treatment steps.
Therapeutic approach:
  • Client-centred, straightforward, and empathetic – focused on practical outcomes and emotional stabilisation.
  • Prescribes medications when needed, but always aims to minimise unnecessary pharmaceutical use.
  • Certified in multiple evidence-based methods: CBT, NLP (Master Practitioner), Ericksonian hypnosis, symbol drama, art therapy, and systemic therapy.
  • Each consultation results in a clear, structured plan – patients leave knowing exactly what to do next.
Experience and background:
  • Member of the German association Gesundheitpraktikerin and the NGO “Mit dem Sonne in jedem Herzen.”
  • More than 18 publications in international peer-reviewed journals, translated into several languages.
  • Volunteer work with Ukrainian refugees and military personnel at the University Clinic of Regensburg.
Book a video appointment
€156
Doctor
5.0(1)

Daria Portnova

Psychiatry31 years of experience

Dr Daria Portnova is a psychiatrist and psychotherapist with over 30 years of clinical experience. She works with adults and adolescents aged 14 and over, providing online psychiatric and psychotherapeutic consultations. In her practice, Dr Portnova supports patients facing the onset of mental health conditions, chronic psychiatric disorders, psychotic symptoms, trauma-related states, and complex emotional crises. Her work is structured and safety-focused, with an emphasis on stabilisation, accurate diagnosis, and long-term improvement in quality of life. Patients consult Dr Daria Portnova for the following concerns: 

  • existential crises and complex life situations;
  • loss, grief, and emotional exhaustion;
  • relationship difficulties, separation, and divorce;
  • psychological and psychiatric trauma, including complex PTSD (cPTSD);
  • anxiety disorders: generalised anxiety disorder and panic disorder;
  • social anxiety and social phobia;
  • obsessive-compulsive disorder (OCD);
  • sleep disorders;
  • depressive disorders;
  • bipolar affective disorder;
  • schizoaffective disorder;
  • schizophrenia;
  • personality disorders.

Dr Portnova combines psychiatric assessment with a psychotherapeutic approach. She works with evidence-based methods, including cognitive behavioural therapy (CBT) and third-wave approaches such as ACT, FACT, and CFT. Consultations are focused on clear clinical understanding, practical recommendations, and ongoing support over time.

Book a video appointment
€116
Doctor

Elizaveta Marinicheva

Psychiatry5 years of experience

Elizaveta Marinicheva is a psychiatrist who has been practising since 2022. She received her medical degree from the University of Milan (Università degli Studi di Milano, UNIMI) and holds official authorisation to practise medicine in Italy (Abilitazione all'esercizio della professione medica). She is a member of the Milan Medical Association (Ordine dei Medici di Milano).

She is currently completing her specialist training in psychiatry at Sapienza University of Rome (Sapienza Università di Roma). She has also received additional training in psychoanalysis and has completed more than 500 hours of personal psychoanalytic therapy.

In her practice, Dr Marinicheva combines a modern medical approach to mental health with careful consideration of each patient's individual history and current condition. When pharmacotherapy is required, treatment decisions are based on the principles of evidence-based medicine and current international clinical guidelines, including NICE, APA, WFSBP and CANMAT.

Dr Marinicheva provides online psychiatry consultations for anxiety, low mood, emotional instability, sleep problems, chronic stress and other conditions affecting mental wellbeing and quality of life. During a consultation, she assesses the patient's symptoms and overall condition, discusses potential treatment approaches and, when clinically appropriate, recommends medication and an appropriate follow-up plan.

Book a video appointment
€166
Doctor

Svitlana Medvedkova

Neurology23 years of experience

Neurologist of the highest qualification category, Doctor of Medical Sciences and Professor, with 23 years of clinical experience and 19 years of teaching experience. Areas of expertise include general neurology, physical and rehabilitation medicine, and medical psychology.

Conditions and areas of care:

  • Acute and chronic vascular diseases of the brain and spinal cord, including stroke prevention

  • Demyelinating diseases, including multiple sclerosis

  • Neurodegenerative diseases, including Parkinson’s disease

  • Disorders of the peripheral nervous system, including spinal conditions, mono- and polyneuropathies, and cranial nerve disorders; autonomic nervous system disorders

  • Migraines, headaches and dizziness

  • Traumatic injuries of the central and peripheral nervous systems

  • Cognitive difficulties, including problems with memory and concentration

  • Emotional and neurotic disorders, including anxiety and depressive symptoms, panic attacks and increased anxiety; fatigue and chronic fatigue syndrome

  • Sleep disorders, including insomnia, difficulty falling asleep and disrupted sleep patterns

  • Rehabilitation following strokes, injuries and other neurological conditions, both in the acute and recovery stages

The doctor follows an evidence-based approach and has participated in international clinical research (GCP) for over 20 years. Their work includes developing personalised prevention, rehabilitation and cognitive programmes.

Consultation format: online consultations and remote follow-up care.

Book a video appointment
€136

Frequently Asked Questions

RILUZOL PMCS 50 mg FILM-COATED TABLETS requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.

The active ingredient in RILUZOL PMCS 50 mg FILM-COATED TABLETS is riluzole. This information helps identify medicines with the same composition but different brand names.

RILUZOL PMCS 50 mg FILM-COATED TABLETS is manufactured by Pro.Med.Cs Praha A.S.. Pharmacy brands and packaging may differ depending on the distributor.

Doctors such as Psychiatrists, Neurologists, General medicine doctors, Pain medicine doctors, Anaesthesiologists may assess whether RILUZOL PMCS 50 mg FILM-COATED TABLETS is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.

The prescription is issued by a doctor after assessing your health. In Spain, RILUZOL PMCS 50 mg FILM-COATED TABLETS is then dispensed in pharmacies with that prescription. An online consultation does not guarantee that a prescription will be issued: the decision always rests with the doctor.

To request an assessment, you can use Oladoctor:

Other medicines with the same active substance (riluzole) include EMYLIF 50 mg ORALLY DISINTEGRATING TABLETS, RILUTEK 50 mg FILM-COATED TABLETS, RILUZOL AUROVITAS 50 mg FILM-COATED TABLETS. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media